1. 1555 BEAUTY, a large randomised controlled trial of beauty care for early stage breast cancer patients receiving adjuvant chemotherapy: Impact on body image-related quality of life. (September 2015) Authors: Saghatchian d'Assignies, M.; Laplanche, A.; Fekih, M.; Pezant, E.; Bouvet, N.; Lacas, B.; Ezenfis, J.; Bourron, A.; Warembourg, D.; Dauchy, S.; Delaloge, S.; Amiel, P. Journal: European journal of cancer Issue: Volume 51:(2015)Supplement 3 Page Start: S222 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Breast Cancer Patients' Experience and Wishes Regarding Communication on Sexual Health: The BEROSE Study. (3rd July 2022) Authors: Aupomerol, M.; Chaltiel, D.; Pautier, P.; Wehrer, D.; Véron, L.; Degousée, L.; Fasse, L.; Guéroult-Accolas, L.; Di Meglio, A.; Scotté, F.; De-Jesus, A.; Vaz-Luis, I.; Delaloge, S.; Lambertini, M.; Pistilli, B. Journal: Cancer investigation Issue: Volume 40:Number 6(2022) Page Start: 483 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Clinical utility of MammaPrint testing in Invasive Lobular Carcinoma: Results from the MINDACT phase III trial. (October 2020) Authors: Metzger, O.; Cardoso, F.; Poncet, C.; Desmedt, C.; Linn, S.; Wesseling, J.; Hilbers, F.; Aalders, K.; Delorenzi, M.; Delaloge, S.; Pierga, J.Y.; Brain, E.; Vrijaldenhoven, S.; Neijenhuis, P.A.; Rutgers, E.; Piccart, M.; van 't Veer, L.; Viale, G. Journal: European journal of cancer Issue: Volume 138(2020)Supplement 1 Page Start: S5 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Contemporary picture of metastatic breast cancer: Characteristics and outcomes of 22, 000 women from the ESME cohort 2008–2016. (October 2020) Authors: Deluche, E.; Antoine, A.; Bachelot, T.; Lardy-cleaud, A.; Dieras, V.; Brain, E.; Jacot, W.; Goncalves, A.; Dalenc, F.; Patsouris, A.; Mathoulin-Pelissier, S.; Courtinard, C.; Perol, D.; Robain, M.; Delaloge, S. Journal: European journal of cancer Issue: Volume 138(2020)Supplement 1 Page Start: S4 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Efficacy of neratinib in hormone receptor-positive (HR+) patients who initiated treatment within 1 year of completing trastuzumab-based adjuvant therapy in HER2+ early-stage breast cancer (BC): subgroup analyses from the phase III ExteNET trial. (March 2019) Authors: Ejlertsen, B.; Holmes, F.A.; Chia, S.K.L.; Iwata, H.; Moy, B.; Delaloge, S.; Xu, F.; Barnett, B.; Chan, A.; Martin, M. Journal: Breast Issue: Volume 44(2019)Supplement 1 Page Start: S18 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Endocrine therapy or chemotherapy as first-line therapy in hormone receptor–positive HER2-negative metastatic breast cancer patients. (May 2018) Authors: Jacquet, E.; Lardy-Cléaud, A.; Pistilli, B.; Franck, S.; Cottu, P.; Delaloge, S.; Debled, M.; Vanlemmens, L.; Leheurteur, M.; Guizard, A.V.; Laborde, L.; Uwer, L.; Jacot, W.; Berchery, D.; Desmoulins, I.; Ferrero, J.M.; Perrocheau, G.; Courtinard, C.; Brain, E.; Chabaud, S. Journal: European journal of cancer Issue: Volume 95(2018) Page Start: 93 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Evaluation of disease-free survival (DFS) as a surrogate for overall survival (OS) in the adjuvant therapy of HER2-positive early breast cancer (EBC) calls for individual-patient data (IPD). (March 2017) Authors: Saad, E.; Delaloge, S.; Mavroudis, D.; Perez, E.; Piccart-Gebhart, M.; Schneider, B.; Wolmark, N.; Buyse, M.; Burzykowski, T. Journal: Breast Issue: Volume 32(2017)Supplement 1 Page Start: S26 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Information needs on nutrition in link to cancer prevention among cancer patients, high-risk individuals and general population – A national cross-sectional study. (April 2023) Authors: Veron, L.; Chaltiel, D.; Raynard, B.; Rassy, N.; Scotté, F.; Charles, C.; Pons, M.; De Jesus, A.; Accolas, L Gueroult; Bergougnoux, A.; Caron, O.; Delaloge, S. Journal: Clinical nutrition ESPEN Issue: Volume 54(2023) Page Start: 421 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Letter to the Editor. Issue 5 (1st August 2003) Authors: Delaloge, S.; Pautier, P.; Duvillard, P. Journal: International journal of gynecological cancer Issue: Volume 13:Issue 5(2003) Page Start: 697 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. New oral targeted therapies for metastatic breast cancer disrupt the traditional patients' management—A healthcare providers' view. (27th December 2016) Authors: Martin, E.; Pourtau, L.; Di Palma, M.; Delaloge, S. Journal: European journal of cancer care Issue: Volume 26:Number 6(2017:Nov.) Page Start: n/a Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗